Diffusion-weighted imaging and FDG PET/CT: predicting the prognoses with apparent diffusion coefficient values and maximum standardized uptake values in patients with invasive ductal carcinoma

被引:56
作者
Choi, Bo Bae [2 ]
Kim, Sung Hun [1 ]
Kang, Bong Joo [1 ]
Lee, Ji Hye [1 ]
Song, Byung Joo [3 ]
Jeong, Seung Hee [4 ]
Yim, Hyeon Woo [4 ]
机构
[1] Catholic Univ Korea, Dept Radiol, Seoul, South Korea
[2] Chungnam Natl Univ, Dept Radiol, Chungnam, South Korea
[3] Catholic Univ Korea, Dept Gen Surg, Seoul, South Korea
[4] Catholic Univ Korea, Coll Med, Clin Res Coordinating Ctr, Dept Prevent Med, Seoul, South Korea
关键词
Invasive ductal carcinoma; breast; magnetic resonance imaging; diffusion magnetic resonance imaging; positron emission tomography; POSITRON-EMISSION-TOMOGRAPHY; PRIMARY BREAST-CANCER; DIFFERENTIAL-DIAGNOSIS; GROWTH-FACTOR; TUMORS; CELLULARITY; ADC; MRI;
D O I
10.1186/1477-7819-10-126
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: FDG PET/CT and DWI are both functional modalities that indirectly represent the biological characteristics of cancer, but there are few studies exploring the association between the two modalities and prognostic factors. Our study attempted to evaluate the mutual association by comparing the prognostic factors, SUVmax value of PET/CT, and ADC values associated with diffusion imaging in invasive ductal carcinoma (IDC) patients. Methods: Patients with pathologically confirmed IDC were recruited. There were 118 patients who underwent MRI, including DWI, FDG PET/CT, and immunohistochemical staining of the surgical specimen. Histologic analysis was done on tumor size, lymph node metastasis, expression of estrogen receptors (ER), progesterone receptors (PR), human epidermal growth factor receptor 2 (HER2), Ki-67, and epidermal growth factor receptors (EGFR). The relationship among ADC values, SUVmax and prognostic factors were evaluated. Results: There was significant association between the ADC value and ER-positive and HER2-negative expression. Significant associations were noted between SUVmax and tumor size, lymph node metastasis, histologic grade, ER and PR expression, EGFR and Ki-67. However, there was no significant correlation between the ADC value and SUVmax. Conclusions: Even though there was no correlation between ADC and SUVmax, both indexes are useful for predicting the prognosis of IDC.
引用
收藏
页数:7
相关论文
共 28 条
[1]  
Ali SH, 2000, CANCER RES, V60, P7094
[2]  
BLACK R, 1983, CLIN ONCOL, V9, P311
[3]   Biologic correlates of 18fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography [J].
Bos, R ;
van der Hoeven, JJM ;
van der Wall, E ;
van der Groep, P ;
van Diest, PJ ;
Comans, EFI ;
Joshi, U ;
Semenza, GL ;
Hoekstra, OS ;
Lammertsma, AA ;
Molthoff, CFM .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (02) :379-387
[4]   Prognostic molecular markers in early breast cancer [J].
Esteva, FJ ;
Hortobagyi, GN .
BREAST CANCER RESEARCH, 2004, 6 (03) :109-118
[5]   Differentiation of clinically benign and malignant breast lesions using diffusion-weighted imaging [J].
Guo, Y ;
Cai, YQ ;
Cai, ZL ;
Gao, YG ;
An, NY ;
Ma, L ;
Mahankali, S ;
Gao, JH .
JOURNAL OF MAGNETIC RESONANCE IMAGING, 2002, 16 (02) :172-178
[6]  
Hatakenaka Masamitsu, 2008, Magn Reson Med Sci, V7, P23, DOI 10.2463/mrms.7.23
[7]   Correlation of apparent diffusion coefficients measured by 3T diffusion-weighted MRI and SUV from FDG PET/CT in primary cervical cancer [J].
Ho, Kung-Chu ;
Lin, Gigin ;
Wang, Jiun-Jie ;
Lai, Chyong-Huey ;
Chang, Chee-Jen ;
Yen, Tzu-Chen .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 (02) :200-208
[8]  
Ikenaga N, 2007, AM SURGEON, V73, P1151
[9]   Fluorine-18 fluoro-2-deoxyglucose positron emission tomography in recurrent rectal cancer: Relation to tumour size and cellularity [J].
Ito, K ;
Kato, T ;
Ohta, T ;
Tadokoro, M ;
Yamada, T ;
Ikeda, M ;
Nishino, M ;
Ishigaki, T ;
Ito, K ;
Gambhir, S .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1996, 23 (10) :1372-1377
[10]   Significance of axillary lymph node metastasis in primary breast cancer [J].
Jatoi, I ;
Hilsenbeck, SG ;
Clark, GM ;
Osborne, CK .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (08) :2334-2340